• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国住院社区获得性肺炎的疾病负担:基于年龄和基础疾病的分析。

Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions.

作者信息

Choi Min Joo, Song Joon Young, Noh Ji Yun, Yoon Jin Gu, Lee Saem Na, Heo Jung Yeon, Yoon Jae Won, Jo Yu Mi, Cheong Hee Jin, Kim Woo Joo

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine Asian Pacific Influenza Institute, Seoul Division of Infectious Diseases, Department of Internal Medicine, Chungbuk National University College of Medicine Division of Infectious Diseases, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea.

出版信息

Medicine (Baltimore). 2017 Nov;96(44):e8429. doi: 10.1097/MD.0000000000008429.

DOI:10.1097/MD.0000000000008429
PMID:29095281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5682800/
Abstract

Pneumonia is a leading cause of hospitalization and mortality worldwide. Despite recognition of the importance of community-acquired pneumonia (CAP) in adults, limited epidemiologic information is available in South Korea. This study aimed to evaluate the disease burden of hospitalized CAP in adults aged ≥19 years and its epidemiologic trend using Health Insurance and Review Assessment (HIRA) data.This is a retrospective study using the HIRA database from year 2009 to 2013. We estimated the incidence rate and direct medical cost of hospitalized CAP in adults aged ≥19 years in South Korea. These were further analyzed with respect to age and underlying medical conditions.During 2009 to 2013, 1216,916 hospitalizations were recorded. On average, the annual age-adjusted incidence rate of hospitalized CAP was 626 per 100,000 persons, with the rate increasing with age. When stratified by age- and risk groups, elderly people ≥75 years showed the highest incidence rate of hospitalized CAP over 5-year study periods. With respect to the risk groups based on underlying medical conditions, incidence rate ratios were 2.04 to 5.86 for the high-risk group versus the low-risk group and 1.28 to 5.49 for the moderate-risk group versus the low-risk group. Overall, mean direct medical cost for hospitalized CAP was 1851 USD per capita during the 5-year period: 1263 USD in the low-risk group, 2353 USD in the moderate-risk group, and 2841 USD in the high-risk group.This study shows that the incidence and medical cost of hospitalized CAP were consistently high over the 5-year study period. In particular, elderly people and adults with underlying medical conditions were at increased risk for hospitalized CAP.

摘要

肺炎是全球住院和死亡的主要原因。尽管人们认识到社区获得性肺炎(CAP)在成人中的重要性,但韩国的流行病学信息有限。本研究旨在利用健康保险审查评估(HIRA)数据评估≥19岁成人住院CAP的疾病负担及其流行病学趋势。

这是一项使用2009年至2013年HIRA数据库的回顾性研究。我们估计了韩国≥19岁成人住院CAP的发病率和直接医疗费用,并按年龄和基础疾病进行了进一步分析。

2009年至2013年期间,共记录了1216916例住院病例。平均而言,住院CAP的年龄调整后年发病率为每10万人626例,且发病率随年龄增长而增加。按年龄和风险组分层时,在5年研究期间,≥75岁的老年人住院CAP发病率最高。就基于基础疾病的风险组而言,高危组与低危组的发病率比值为2.04至5.86,中危组与低危组的发病率比值为1.28至5.49。总体而言,5年期间住院CAP的人均直接医疗费用为1851美元:低危组为1263美元,中危组为2353美元,高危组为2841美元。

本研究表明,在5年研究期间,住院CAP的发病率和医疗费用一直居高不下。特别是,老年人和有基础疾病的成年人住院CAP的风险增加。

相似文献

1
Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions.韩国住院社区获得性肺炎的疾病负担:基于年龄和基础疾病的分析。
Medicine (Baltimore). 2017 Nov;96(44):e8429. doi: 10.1097/MD.0000000000008429.
2
Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea.儿童社区获得性肺炎住院负担:越南、马来西亚、印度尼西亚和大韩民国的回顾性横断面研究。
Hum Vaccin Immunother. 2018 Jan 2;14(1):95-105. doi: 10.1080/21645515.2017.1375073. Epub 2017 Nov 10.
3
Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.社区获得性肺炎住院患者的发病率、直接费用及住院时长:一项全国性回顾性索赔数据库分析
Vaccine. 2015 Jun 22;33(28):3193-9. doi: 10.1016/j.vaccine.2015.05.001. Epub 2015 May 14.
4
The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.社区获得性肺炎(CAP)住院患者的年度经济负担:一项回顾性美国队列研究。
Curr Med Res Opin. 2020 Jan;36(1):151-160. doi: 10.1080/03007995.2019.1675149. Epub 2019 Oct 17.
5
Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.退伍军人健康管理局中社区获得性肺炎的临床和经济负担,2011年:一项回顾性队列研究
Infection. 2015 Dec;43(6):671-80. doi: 10.1007/s15010-015-0789-3. Epub 2015 May 17.
6
Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.50 岁及以上商业保险美国成年人中按年龄和风险划分的社区获得性肺炎发作费用。
Appl Health Econ Health Policy. 2013 Jun;11(3):251-8. doi: 10.1007/s40258-013-0026-0.
7
Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases.50岁以上韩国成年人中按年龄和基础疾病分层的肺炎疾病负担。
Korean J Intern Med. 2014 Nov;29(6):764-73. doi: 10.3904/kjim.2014.29.6.764. Epub 2014 Oct 31.
8
Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality.美国因肺炎住院的成年人:发病率、流行病学和死亡率。
Clin Infect Dis. 2017 Nov 13;65(11):1806-1812. doi: 10.1093/cid/cix647.
9
CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.CAPECO:初级保健中社区获得性肺炎的成本评估。
Vaccine. 2016 Apr 27;34(19):2275-80. doi: 10.1016/j.vaccine.2016.03.013. Epub 2016 Mar 12.
10
Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.荷兰老年人社区获得性肺炎的住院费用:一项观察性研究。
BMC Infect Dis. 2016 Sep 2;16(1):466. doi: 10.1186/s12879-016-1783-9.

引用本文的文献

1
Severity of Respiratory Viral Diseases and the Impacts of Underlying Medical Conditions During the Omicron Subvariant Dominant Epidemics-A Comparative Study of SARS-CoV-2, Influenza Virus and Respiratory Syncytial Virus.奥密克戎变异株主导流行期间呼吸道病毒疾病的严重程度及基础疾病的影响——严重急性呼吸综合征冠状病毒2、流感病毒和呼吸道合胞病毒的比较研究
Pathogens. 2025 May 29;14(6):543. doi: 10.3390/pathogens14060543.
2
Abnormal serum phosphorus was associated with the outcome of community-acquired pneumonia.血清磷异常与社区获得性肺炎的预后相关。
Front Nutr. 2025 Jun 4;12:1435805. doi: 10.3389/fnut.2025.1435805. eCollection 2025.
3

本文引用的文献

1
Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality.美国因肺炎住院的成年人:发病率、流行病学和死亡率。
Clin Infect Dis. 2017 Nov 13;65(11):1806-1812. doi: 10.1093/cid/cix647.
2
Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea.韩国老年人肺炎球菌疫苗接种策略的成本效益
PLoS One. 2017 May 12;12(5):e0177342. doi: 10.1371/journal.pone.0177342. eCollection 2017.
3
Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data.
Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea.
韩国耐多药鲍曼不动杆菌和铜绿假单胞菌所致肺炎的社会经济负担。
Sci Rep. 2022 Aug 17;12(1):13934. doi: 10.1038/s41598-022-18189-6.
4
Continuing Quality Assessment Program Improves Clinical Outcomes of Hospitalized Community-Acquired Pneumonia: A Nationwide Cross-Sectional Study in Korea.持续质量评估计划改善了住院社区获得性肺炎的临床结局:韩国的一项全国性横断面研究。
J Korean Med Sci. 2022 Aug 1;37(30):e234. doi: 10.3346/jkms.2022.37.e234.
5
Cost-Benefit Analysis of Tafenoquine for Radical Cure of Malaria in Korea.韩国青蒿琥酯根治疟疾的成本效益分析。
J Korean Med Sci. 2022 Jul 11;37(27):e212. doi: 10.3346/jkms.2022.37.e212.
6
The hospitalization burden of all-cause pneumonia in China: A population-based study, 2009-2017.中国全因性肺炎的住院负担:一项基于人群的研究,2009 - 2017年
Lancet Reg Health West Pac. 2022 Apr 6;22:100443. doi: 10.1016/j.lanwpc.2022.100443. eCollection 2022 May.
7
Peak Voluntary Cough Flow and Oropharyngeal Dysphagia as Risk Factors for Pneumonia.最大自主咳嗽流量和口咽吞咽困难作为肺炎的危险因素
Ann Rehabil Med. 2021 Dec;45(6):431-439. doi: 10.5535/arm.21068. Epub 2021 Dec 31.
8
Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study.在迪拜成人肺炎患者的实际疾病成本评估——一项索赔数据库研究。
PLoS One. 2021 Sep 1;16(9):e0256856. doi: 10.1371/journal.pone.0256856. eCollection 2021.
9
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.制定大流行 COVID-19 疫苗分配框架:韩国的一项改良德尔菲共识研究。
J Korean Med Sci. 2021 Jun 14;36(23):e166. doi: 10.3346/jkms.2021.36.e166.
10
Trend of Antibiotic Usage for Hospitalized Community-acquired Pneumonia Cases in Korea Based on the 2010-2015 National Health Insurance Data.基于 2010-2015 年国家健康保险数据的韩国住院社区获得性肺炎病例抗生素使用趋势。
J Korean Med Sci. 2020 Dec 7;35(47):e390. doi: 10.3346/jkms.2020.35.e390.
实现韩国健康保险审查与评估(HIRA)数据作为健康研究资源的价值潜力:HIRA数据的优势、局限性、应用及最佳使用策略
J Korean Med Sci. 2017 May;32(5):718-728. doi: 10.3346/jkms.2017.32.5.718.
4
Severe community-acquired pneumonia: timely management measures in the first 24 hours.重症社区获得性肺炎:最初24小时的及时管理措施
Crit Care. 2016 Aug 28;20(1):237. doi: 10.1186/s13054-016-1414-2.
5
Rates of pneumonia among children and adults with chronic medical conditions in Germany.德国患有慢性疾病的儿童和成人的肺炎发病率。
BMC Infect Dis. 2015 Oct 30;15:470. doi: 10.1186/s12879-015-1162-y.
6
Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes.肺炎球菌尿抗原检测的临床实用性,按疾病严重程度和血清型分层
J Infect Chemother. 2015 Sep;21(9):672-9. doi: 10.1016/j.jiac.2015.06.003. Epub 2015 Jun 19.
7
Rates of pneumococcal disease in adults with chronic medical conditions.慢性基础疾病成人的肺炎球菌病发病率。
Open Forum Infect Dis. 2014 May 27;1(1):ofu024. doi: 10.1093/ofid/ofu024. eCollection 2014 Mar.
8
Predictors of viral pneumonia in patients with community-acquired pneumonia.社区获得性肺炎患者病毒性肺炎的预测因素。
PLoS One. 2014 Dec 22;9(12):e114710. doi: 10.1371/journal.pone.0114710. eCollection 2014.
9
Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe.西欧常规儿童免疫规划之外的肺炎球菌免疫接种建议。
Adv Ther. 2014 Oct;31(10):1011-44. doi: 10.1007/s12325-014-0157-1. Epub 2014 Oct 10.
10
Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis.13 价肺炎球菌结合疫苗在美国上市 2 年后对住院的影响:时间序列分析。
Lancet Respir Med. 2014 May;2(5):387-94. doi: 10.1016/S2213-2600(14)70032-3. Epub 2014 Mar 10.